Page last updated: 2024-10-27

fexofenadine and Syncope

fexofenadine has been researched along with Syncope in 2 studies

fexofenadine: a second generation antihistamine; metabolite of the antihistaminic drug terfenadine; structure in first source; RN refers to HCl
fexofenadine : A piperidine-based anti-histamine compound.

Syncope: A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McCord, JL1
Pellinger, TK1
Lynn, BM1
Halliwill, JR1
Pinto, YM1
van Gelder, IC1
Heeringa, M1
Crijns, HJ1

Trials

1 trial available for fexofenadine and Syncope

ArticleYear
Potential benefit from an H1-receptor antagonist on postexercise syncope in the heat.
    Medicine and science in sports and exercise, 2008, Volume: 40, Issue:11

    Topics: Adolescent; Adult; Exercise; Female; Histamine H1 Antagonists, Non-Sedating; Hot Temperature; Humans

2008

Other Studies

1 other study available for fexofenadine and Syncope

ArticleYear
QT lengthening and life-threatening arrhythmias associated with fexofenadine.
    Lancet (London, England), 1999, Mar-20, Volume: 353, Issue:9157

    Topics: Aged; Electrocardiography; Histamine H1 Antagonists; Humans; Long QT Syndrome; Male; Syncope; Tachyc

1999